Author:
Rosca I. D.,Vergnaud J. M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference28 articles.
1. Aïnaoui A, Vergnaud JM (2000) Effect of the nature of the polymer and the process of drug release (diffusion or erosion) for oral dosage forms. Comput Theor Polym Sci 10:383–390
2. Aïnaoui A, Siepmann J, Bodmeier R, Vergnaud JM (2001) Calculation of the dimensions of dosage forms with release controlled by diffusion for in vivo use. Euro J Pharm Biopharm 51:17–24
3. Breilh D, Pobel C, Saux MC, Maire P, Vergnaud JM, Saidna M, Jelliffe R, Barbault X (2001) Mixed pharmacokinetic population study and diffusion model to describe ciprofloxacin lung concentrations. Comput Biol Med 31:147–155
4. Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA, Ward A (1998) Ciprofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drug Eval Drugs 35:373–447
5. Cardot JM, Beyssac E (1993) In vitro/in vivo correlations: scientific implications and standardisation. Eur J Drug Metabol Pharmacol 18(1):113–120